Patents by Inventor Dirk L. Teagarden

Dirk L. Teagarden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7829100
    Abstract: A composition comprising: (a) one to three bioactive agents; and (b) a modified liquid vehicle; wherein immediately after manufacture of the composition, said composition can be administered to a host such that the one to three bioactive agents is released to the host on a sustained basis is provided.
    Type: Grant
    Filed: November 10, 2003
    Date of Patent: November 9, 2010
    Inventors: Dirk L. Teagarden, Nancy J. Britten, Scott A. Brown, James F. Caputo, Leslie C. Eaton, Ondrej Hendl, Syed F. Huda, Harry M. King, Susan M. Machkovech, Randal Lee Schapaugh, Stanley M. Speaker, Jean M. Steele, Ching-Chiang Su, Terry R. Urban, Niki A. Waldron, Monica L. Whitmire
  • Publication number: 20040142027
    Abstract: A composition comprising:
    Type: Application
    Filed: November 10, 2003
    Publication date: July 22, 2004
    Inventors: Dirk L. Teagarden, Nancy J. Britten, Scott A. Brown, James F. Caputo, Leslie C. Eaton, Ondrej Hendl, Syed F. Huda, Harry M. King, Susan M. Machkovech, Randal Lee Schapaugh, Stanley M. Speaker, Jean M. Steele, Ching-Chiang Su, Terry R. Urban, Niki A. Waldron, Monica L. Whitmire
  • Publication number: 20020110561
    Abstract: A composition comprising:
    Type: Application
    Filed: September 7, 2001
    Publication date: August 15, 2002
    Inventors: Dirk L. Teagarden, Nancy J. Britten, Scott A. Brown, James F. Caputo, Leslie C. Eaton, Ondrej Hendl, Syed F. Huda, Harry M. King, Susan M. Machkovech, Randal Lee Schapaugh, Stanley M. Speaker, Jean M. Steele, Ching-Chiang Su, Terry R. Urban, Niki A. Waldron, Monica L. Whitmire
  • Patent number: 5770230
    Abstract: A stable and lyophilized formulation of prostaglandin E-1 made by the process comprising a) dissolving PGE-1 in a solution of lactose and tertiary butyl alcohol wherein said tertiary butyl alcohol is present in an amount of from about 15% to about 33% volume/volume and the ratio of said lactose to PGE-1 is from about 40,000 to 1 to about 10,000 to 1 weight/weight whereby a formulation of PGE-1 dispersed in lactose is formed; b) adjusting and maintaining the pH of said formulation from about 3.5 to about 6 with an organic acid buffer, c) freezing said formulation to about -50.degree. C.; and d) drying said formulation to obtain a moisture content of less than 1% by dry weight and a tertiary butyl alcohol content of less than 3% by dry weight. Preferably, step c) includes after freezing said formulation to about -50.degree. C., warming to about -25.degree. C. for about 2 hours then refreezing to about -50.degree. C.
    Type: Grant
    Filed: December 30, 1996
    Date of Patent: June 23, 1998
    Assignee: Pharmacia & Upjohn Company
    Inventors: Dirk L. Teagarden, William J. Petre, Paul M. Gold
  • Patent number: 5741523
    Abstract: A stable and lyophilized formulation of prostaglandin E-1 made by the process comprising a) dissolving PGE-1 in a solution of lactose and tertiary butyl alcohol wherein said tertiary butyl alcohol is present in an amount of from about 15% to about 33% volume/volume and the ratio of said lactose to PGE-1 is from about 40,000 to 1 to about 10,000 to 1 weight/weight whereby a formulation of PGE-1dispersed in lactose is formed; b) adjusting and maintaining the pH of said formulation from about 3.5 to about 6 with an organic acid buffer; c) freezing said formulation to about -50.degree. C.; and d) drying said formulation to obtain a moisture content of less than 1% by dry weight and a tertiary butyl alcohol content of less than 3% by dry weight. Preferably, step c) includes after freezing said formulation to about -50.degree. C., warming to about -25.degree. C. for about 2 hours then refreezing to about 50.degree. C.
    Type: Grant
    Filed: March 28, 1996
    Date of Patent: April 21, 1998
    Assignee: Pharmacia & Upjohn Company
    Inventors: Dirk L. Teagarden, William J. Petre, Paul M. Gold
  • Patent number: 4393065
    Abstract: A process for increasing productivity in healthy animals comprising the administration of a compound of the formula ##STR1## in association with the animal feed water or salt rations. Compositions comprising a compound of the above formula for daily administration or long acting forms are disclosed.
    Type: Grant
    Filed: April 14, 1981
    Date of Patent: July 12, 1983
    Assignee: The Upjohn Company
    Inventors: Melvin J. DeGeeter, John M. McCall, Dirk L. Teagarden